Roivant Sciences Ltd. — Director's Dealing 2025

Dec 30, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2025-12-23

Reporting Person: Pulik Richard (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-23	Common Shares	M	260000	$3.85	Acquired	646144	Direct
2025-12-23	Common Shares	S	260000	$22.45	Disposed	386144	Direct
2025-12-23	Common Shares	S	146731	$22.39	Disposed	239413	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-12-23	Stock Option (Right to Buy)	$3.85	M	260000	Disposed	2032-04-19	Common Stock (260000)	Direct

Footnotes

F1: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

F2: These Common Shares were sold in multiple transactions at prices ranging from $22.37 to $22.51, inclusive.

F3: These Common Shares were sold in multiple transactions at prices ranging from $22.28 to $22.54, inclusive.

F4: Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation).